Purine derivatives as A2A agonists

Details for Australian Patent Application No. 2007271944 (hide)

Owner Novartis AG

Inventors Fairhurst, Robin Alec; Taylor, Roger John

Agent Davies Collison Cave

Pub. Number AU-A-2007271944

PCT Pub. Number WO2008/006563

Priority 06117168.2 13.07.06 EP

Filing date 11 July 2007

Wipo publication date 17 January 2008

International Classifications

C07D 473/16 (2006.01) Heterocyclic compounds containing purine ring systems

A61K 31/52 (2006.01)

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

C07H 19/167 (2006.01) Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical

Event Publications

5 February 2009 PCT application entered the National Phase

  PCT publication WO2008/006563 Priority application(s): WO2008/006563

10 May 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007271964-Pyrimidine derivatives as ALK-5 inhibitors

2007271928-Pyrrolopyrimidines for pharmaceutical compositions